RELATIONSHIP BETWEEN SOCIAL SUPPORT TO THE QUALITY OF LIFE IN CANCER PATIENTS DR. Sarjito YOGYAKARTA

ABSTRACT: Background: Cancer is a rapidly developed disease which contributes in major death around the world. In general, cancer patients have an exaggerated response. As a result, they do resentment against themselves and others. Thus, social supports are needed to improve their quality of life Objective: The aim of this research is to discover the correlation between social support and quality of lifeof the cancer patients.This research aims to know the different degrees of social support and quality of life of cancer patients. Methods:Non experimental descriptive analysis using cross-sectional method was applied in the research conducted in DR. Sardjito Hospital Yogyakarta. There are 32 respondents (n=32) who have received a quality of life’s questionnaire developed by European Organization for Research and Treatment of Cancer Quality of Life Close to 30 (EORTC QLQ C-30) and a social support’s questionnaire developed by Multidimensional Scale of Perceived Social Support (MSPSS). Nonparametrik test spaerman with value data α< 0.05 and 95% confidence interval value was used in the research data analysis. Result: This study shows that there is no correlation between social support and the quality of life of the cancer patients. There is no low level of social supports. Moreover, high social supports value is found in 5 patients and medium social supports is found in 27 patients. The median is 36 and min-max is 31-46. The social supports with general health status of the domain have value p=0,525 (p < 0.05). There is no difference between the level of social supports and quality of life of cancer patients. Social supports with diarrhoea symptoms have significant value p=0,029 ( p 0.05 ). Conclusion: In conclusion, there is no correlation between the social supports and the quality of life of cancer patients. Furthermore, there is no difference between the level the of social supports and the quality of life of cancer patients.